The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.
from NYT > Health https://ift.tt/i1DhF8I
Subscribe to:
Post Comments (Atom)
-
Low density lipoprotein or simply known as cholesterol is dangerous to the heart and can lead to heart attack and stroke, but the good thing... -
Unusual opioids are infiltrating street drugs. Knoxville’s top forensic doctor is on the front lines, pressing to quickly identify the most ...
-
A long stay in intensive care can bring physical, cognitive and mental health challenges that can take months or longer to resolve. from N...
No comments:
Post a Comment